Immunotherapy in the Management of Lung Cancer

Immunotherapy in the Management of Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Dades bibliogràfiques
Autor principal:	Tasnim, Humayra
Altres autors:	khan, Tanisha Tabassum Sayka
Format:	Thesis
Idioma:	en_US
Publicat:	Brac University 2022
Matèries:	Lung cancer Immunotherapy Cytokines Checkpoint inhibitors Adoptive cell therapy Vaccines Cancer > Treatment Cancer > Immunotherapy
Accés en línia:	http://hdl.handle.net/10361/17515

Ítems similars

Current practice and approaches of immunotherapy in Cancer treatment
per: Khondokar, Faiza
Publicat: (2022)

A review on targeted therapies for lung cancer
per: Ashraf, Anushey
Publicat: (2023)

Immunotherapy in the treatment of renal cancer
per: Shimu, Sumaya
Publicat: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
per: Ratu, Tabassum
Publicat: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
per: Fred, Namanda Rogers
Publicat: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
per: Rahman, Samia
Publicat: (2022)

CAR-T cell Therapy in B-cell Lymphoma
per: Faruk, Asef
Publicat: (2020)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Flora, Sanzida Alam
Publicat: (2024)

Dendritic cell vaccine for the treatment of cancer
per: Haque, Tanzila
Publicat: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
per: Abir, Shifaty Nur
Publicat: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
per: Bristy, Israt Zerin
Publicat: (2021)

Role of toll-like receptors in cancer immunotherapy– a review
per: Khan, Rezia Nowrin
Publicat: (2021)

Stem cell in cancer disease cure vs cause
per: Chowdhury, Marisha Mansur
Publicat: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024)

Molecules associated with the development of lung cancer
per: Rahman, Adree, et al.
Publicat: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
per: Rahman, Sanjida
Publicat: (2024)

Potential of liposomes for the treatment of lung cancer- a review
per: Mim, Shanzida
Publicat: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
per: Rahman, Tasnim
Publicat: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
per: Tania, Umme
Publicat: (2023)

A review on recent advances in drugs for lung cancer treatment
per: Noor, Fouzia
Publicat: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
per: Jeba, Joynob
Publicat: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
per: Razna, Amrin Islam
Publicat: (2019)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
per: Meem, Manila
Publicat: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
per: Islam, Saidul
Publicat: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
per: Pial, Sazia Afrin
Publicat: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
per: Paul, Pulock
Publicat: (2024)

Stem cells as therapeutic carrier in cancer treatment
per: Anika, Mysha Yeasmin
Publicat: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
per: Emon, Kamrul Hasan
Publicat: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
per: Shabnam, Musharrat
Publicat: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
per: Zangmo, Thinley
Publicat: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
per: Hoque, Ismoth Ara
Publicat: (2024)

A comprehensive review on drug repurposing in cancer treatment
per: Sarkar, Onusree
Publicat: (2024)

Lung cancer detection and classification using machine learning
per: Arefin, Mahbubul, et al.
Publicat: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
per: Nandy, Aditi
Publicat: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
per: Alam, Kazi Tasnuva
Publicat: (2022)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
per: Pecorino, Lauren
Publicat: (2012)

Statistics and informatics in molecular cancer research

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
per: Khan, Muidul Hasan
Publicat: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
per: Kamal, Tasnova
Publicat: (2019)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
per: Hasan, Amit
Publicat: (2024)